Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer-Reference-Cited by-同舟云学术

Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer

Published:2016-11 Issue:11 Volume:27 Page:2032-2038
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Janku F.,Johnson L.K.,Karp D.D.,Atkins J.T.,Singleton P.A.,Moss J.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/27/11/2032/19446556/mdw317.pdf

Reference41 articles.

1. The mu opioid receptor: a new target for cancer therapy?;Singleton;Cancer,2015

2. Development of peripheral opioid antagonists’ new insights into opioid effects;Moss;Mayo Clin Proc,2008

3. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth;Gupta;Cancer Res,2002

4. Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesis;Singleton;Mol Cancer Ther,2008

5. Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation;Singleton;Microvasc Res,2006

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opioids and the Gastrointestinal Tract: The Role of Peripherally Active µ-Opioid Receptor Antagonists in Modulating Intestinal Permeability;American Journal of Gastroenterology;2024-06-13

2. Anesthesia and cancer recurrence: a narrative review;Anesthesia and Pain Medicine;2024-04-30

3. Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy;Cancers;2024-03-21

4. Opioids and Immunosuppression: Clinical Evidence, Mechanisms of Action, and Potential Therapies;Palliative Medicine Reports;2024-02-01

5. Impact of Opioid Use on Duration of Therapy and Overall Survival for Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors;Current Oncology;2024-01-03